评估早期阶段剂量检测试验协议的报告质量:方法论审查
Guillermo Villacampa1, Dhrusti Patel1, Haiyan Zheng2
1Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), United Kingdom.
早期阶段剂量检测试验协议的报告质量在65.1%下是不理想的. 为了严格的试验进行和可重复性,需要提高完整性和透明度.
科学领域:
- 临床试验方法论 临床试验方法论
- 药物开发研究 药物开发研究
- 制药科学 制药科学
背景情况:
- 早期阶段的剂量检测试验正在演变,创新的设计结合了I期和II期.
- 目前对于这些组合阶段试验协议的报告准则缺乏.
- 在这些关键的试验协议中,报告的质量仍然没有得到评估.
研究的目的:
- 评估早期阶段剂量检测试验协议的报告质量.
- 确定协议报告中的优势和弱点.
- 为制定具体报告准则提供信息.
主要方法:
- 来自ClinicalTrials.gov (2017-2023) 的106个瘤和非瘤早期剂量检测试验协议的横截面研究.
- 使用一个结合SPIRIT 2013陈述项和剂量确定特定项的检查清单.
- 评估了充分报告项目的总体比例作为主要终点.
主要成果:
- 总体报告质量为65.1%,表明完整性不足.
- 报告质量在各个项目之间差异很大 (9.4%-100%).
- 瘤学协议报告质量低于非瘤学;更大的样本大小和行业资金与更好的报告相关.
结论:
- 早期阶段剂量检测试验协议的总体报告质量是不理想的.
- 加强完整性和透明度对于严格的试验进行,可重复性和外部审查至关重要.
- 制定具体的报告准则是有必要的,以提高协议质量.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
相关概念视频
Preclinical Development: Overview
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
